Historical Financials in USD and H12025 OPEX (Unaudited)
Filed with ASX · · 10 pages · English
Telix Pharmaceuticals Limited on 6ix
Earlier from Telix Pharmaceuticals
- Telix H1 2025 Results: Investor Webcast Notification
- Telix Reports US$204M Q2 Revenue, Up 63% YOY
- Gozellix Receives Permanent HCPCS Code
- Illuccix Approved in U.S. for Patient Selection for Pre-Taxane RLT
- Telix Precision Medicine Announces AlFluor Radiochemistry Platform
Later from Telix Pharmaceuticals
- Telix H1 2025 Appendix 4D and Interim Report
- Telix H1 2025 Results Presentation
- Telix H1 2025 Results Announcement
- Telix to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference and H.C. Wainwright 27th Annual Global Investment Conference
- Telix Provides Regulatory Update on TLX250-CDx
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals